is retatrutide glp 3 Reta (GLP-3) research product Retatrutide | Triple Agonist Research

Average weekly loss: 0.51.5 kg (13 lbs) Average monthly loss : 26 kg (413 lbs) Results vary based on dose, lifestyle, starting weight, and metabolic health Average weekly loss ranges from 0.251 kg (0.52 lbs) for most patients, with higher early losses possible in some individuals

Shop Medications , GLP-1 receptor agonists are prescription medications that mimic hormones your body naturally produces

Of course, we want most of the weight thats lost to be fat and not muscle

Weeks 3-4: Resolution at Stable Dose By weeks 3-4 at the same dose, diarrhea resolves for most users

Other more seriousthough less commonrisks: pancreatitis, gallbladder disease, changes in thyroid C-cells (in rodents), and rare digestive complications

Quality sleep helps maintain proper hormone levels and supports overall health